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Abstract
Hyperkalemia is a potentially lethal condition. Pseudohyperkalemia should be always excluded before implementing treatment to prevent inappro-
priate cause of hypokalemia – equally a potentially lethal condition. Here we present a case report of a 62 year female with chronic myeloproliferati-
ve disorder, i.e. essential thrombocythemia. The laboratory test results for potassium concentration were 6.3 mmol/L, for platelet count 1305 x109/L 
and for leukocyte count 39.8 x109/L. This was due to a temporary drug withdrawal after a surgical intervention for gastric bleeding. Potassium con-
centration in lithium heparin plasma collected in a vacuum tube without gel separator and in whole blood syringe were 4.6 mmol/L and 3.4 mmol/L, 
respectively. It means that mechanical stress such as centrifugation can contribute to spurious hyperkalemia.
Prior to reporting unexpected hyperkalemia result, pseudohyperkalemia should always be considered by the laboratory. Such potassium results 
require investigation in case it is pseudohyperkalemia, which may be due to thrombocytosis and leukocytosis. In cases where thrombocytosis or 
leukocytosis exists, an interpretative comment indicating these conditions inserted with the results of the potassium concentration can increase 
awareness for more accurate patient care decisions.
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When patients’ results are interpreted, the total 
testing process which includes pre-analytical, ana-
lytical and post-analytical phases should be taken 
into account (1).
Hyperkalemia is a potentially lethal condition. Dif-
ferential diagnosis is broad and includes decreased 
glomerular filtration rate, acidemia, drugs interfer-
ing with potassium metabolism (e.g. digoxin) and 
spurious hyperkalemia due to pre-analytical con-
ditions (2).
In some cases a problem in the pre-analytical 
phase can be recognized during the interpreta-
tion of laboratory test results (3). Pseudohyper-
kalemia due to thrombocytosis or leukocytosis is 
an example of such situation. Pseudohyper-
kalemia should be considered whenever in-
creased platelets or leukocytes in blood count co-
incide with unexplained serum hyperkalemia, typ-
ically in a patient who is without renal failure or 
acidosis or who does not take drugs such as angio-
tensin converting enzyme inhibitors and cardiac 
glycosides (4).
Pseudohyperkalemia can be confirmed by deter-
mining plasma potassium in vacuum tubes with 
lithium heparin after centrifugation, and/or by 
whole blood potassium determination in electro-
lyte balanced lithium heparin syringe (5).
Pseudohyperkalemia should only be considered 
when the serum potassium concentration exceeds 
that of plasma by at least 0.4 mmol/L (6). To reduce 
inappropriate treatment of hyperkalemia the dif-
ference of 1.0 mmol/L between serum and plasma 
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was found practical. Whole blood is recommend-
ed for potassium measurement (7).
Mechanical stress such as centrifugation can lead to 
spurious hyperkalemia in patients with chronic lym-
phocytic leukaemia or acute myeloid leukaemia 
due to increased fragility of their white blood cells 
(8). The added value of this case report is showing 
the difference in results between these two possi-
ble ways of confirming pseudohyperkalemia.
Case report
Informed consent
The patient gave informed consent to all relevant 
and related procedures in a form of a handwritten 
signature before the procedures were performed. 
The publication of this case report was approved 
by the Tomas Bata hospital Ethics committee.
Case and methods description
A 62 years old woman was urgently admitted to 
the surgery department for bleeding from gastric 
ulcer with haemorrhagic shock. She was success-
fully operated.
Her chronic medical history included diabetes 
mellitus, chronic myeloproliferative disorder of es-
sential thrombocythemia type with the presence 
of Janus kinase 2 V617F mutation, and chronic he-
patic disease, probably non-alcoholic fatty liver 
disease. She was regularly taking hydroxylcarba-
mide 500 mg daily and insulin. The hydroxycarba-
mide medication was discontinued because of 
gastrointestinal bleeding.
Her blood count, electrolytes, kidney function and 
other biochemistry laboratory tests were taken 12 
days after the surgery. The tests revealed serum hy-
perkalemia of 6.3 mmol/L. Blood count revealed 
leukocytosis and thrombocytosis (Table 1). Her esti-
mated glomerular filtration rate was decreased. She 
received transfusions during the operation. Labora-
tory tests were measured on a daily basis.
Gradual increase in both serum potassium con-
centration and platelet number was observed af-
ter surgery. Platelets increased from 245 to 1392 
x109/L. Serum potassium concentration increased 
from 4.7 to 6.4 mmol/L. The correlation between 
serum potassium concentration and platelet count 
was found.
Our department has two checkpoint levels in re-
porting laboratory test results. At first level, a bio-
medical scientist evaluates the effect of haemoly-
sis, lipaemia and icterus, which are measured auto-
matically in all samples. Serum potassium concen-
tration was not affected by these variables. Elec-
trolytes were measured repeatedly within few 
minutes with the same results in the same sample. 
At the second checkpoint, the clinical plausibility 
of all laboratory results is assessed. An interpreta-
tive comment was added in this case: “Pseudohy-
perkalemia due to thrombocytosis and leukocyto-
sis is suspected. New sampling to lithium heparin 
tube or a measurement of plasma electrolytes in 
syringe for a blood gas analysis is recommended.”. 
This information was also phoned to the surgery 
department and the information about the phone 
call was recorded in the laboratory information 
system.
Both determinations were performed and con-
firmed spurious hyperkalemia. Results are shown 
in Table 1.
Laboratory analyses
VACUETTE® red top 6 mL tube (Greiner Bio-One 
GmbH, catalogue number 476092, Kremsmunster, 
Austria) with clot activator and without gel separa-
tor was used for venous blood collection. The sep-
aration of cells from serum was performed within 
1  hour after collection. The sample was centri-
fuged for 10 minutes at 1500xg. Serum potassium 
concentration and other serum tests were meas-
ured on ci16200 Abbott Architect analyser (Abbott 
Laboratories, Illinois, USA).
Whole blood pH, pCO2, pO2, glucose and electro-
lytes tests were performed on Radiometer ABL 
800 FLEX blood gas analyser (Radiometer, Bron-
shoj, Denmark) by electrochemistry methods. The 
potentiometric principle is applied in the meas-
urement of pH, pCO2 and electrolytes. The amper-
ometry (Clark electrode) is applied in measure-
ment of pO2 and glucose. This is the point of care 
testing analyser which is not present in the central 
laboratory.
https://doi.org/10.11613/BM.2018.011002 Biochem Med (Zagreb) 2018;28(1):011002 
  3
Šálek T.  Pseudohyperkalemia due to thrombo- and leukocytosis 
An anaesthesiologist performed the blood collec-
tion from left femoral artery to Radiometer dry 
electrolyte-balanced lithium heparin syringe (cata-
logue number 956-552 PICO 50). The tests were 
measured within 5 minutes after collection. This 
sample was not checked for haemolysis. VACUETTE® 
green top Lithium Heparin coated 3 mL tube with-
out gel separator (Greiner Bio-One GmbH, cata-
logue number 454082, Kremsmunster, Austria) was 
used for venous blood collection. The separation of 
cells from plasma was performed within 15 minutes 
after collection (the sample was taken to the labora-
tory immediately after collection). The sample was 
centrifuged for 10 minutes at 1500xg. Plasma elec-
trolytes were measured on ci16200 Abbott Archi-
tect analyser (Abbott Laboratories, Illinois, USA). 
Blood count was measured on COULTER® LH 750 
haematology analyser (Beckman Coulter, Brea, USA).
All 3 samples were taken in a lying position. The 
first and the third ones were delivered to the labo-
ratory manually. Only the first sample was taken in 
fasting state. It explains the elevated plasma glu-
cose in a diabetic patient after meal. The first sam-
ple was accepted by laboratory at 8:10 a.m. and re-
ported at 9:19 a.m. The communication with clini-
cians started at 9:19 a.m. The next sample was col-
lected at 9:34 a.m. and reported at 9:37 a.m. (point 
of care testing analyser). This second sample con-
firmed pseudohyperkalemia.
Results
The patient had a combination of laboratory test 
results of serum hyperkalemia, thrombocytosis 
and leukocytosis. Potassium in plasma was lower 




Serum Whole blood Li-heparin plasma
Serum free haemoglobin (g/L) 0.09 0.00 0.00 – 0.25
Glucose (mmol/L) 5.5 10.2 / 3.9 – 5.5 (whole blood, plasma);3.8 – 5.5 (serum)
Sodium (mmol/L) 131 128 132 136 – 144
Potassium (mmol/L) 6.3 3.4 4.6 3.8 – 5.1 (serum);3.5 – 4.8 (whole blood, plasma)
Chloride (mmol/L) 99 104 104 95 – 107
Urea (mmol/L) 7.5 / / 2.0 – 6.7
Creatinine (µmol/L) 114 / / 49 - 90
eGFR (mL/s/1.73m2) 0.74 / / 1.50 – 2.50
Albumin (g/L) 34.4 / / 35.0 – 52.0
C-reactive protein (mg/L) 22 / / < 3
White blood cells (x109/L) 39.8 / / 4.0 – 10.0
Red blood cells (x1012/L) 4.34 / / 3.80 – 5.20
Platelets (x109/L) 1305 / / 150 – 400
Whole blood pH / 7.421 / 7.360 – 7.440
Whole blood pCO2 (kPa) / 3.72 / 4.60 – 6.00
Whole blood pO2 (kPa) / 11.60 / 10.67 - 14.40
Base excess (mmol/L) / - 5.8 / - 2.5 – 2.5
Measured saturation of haemoglobin (%) / 96.7 / 95.0 – 99.0
eGFR - estimated glomerular filtration rate using the Chronic Kidney Disease – Epidemiology Collaboration (CKD-EPI) equation.
Table 1. The patient’s laboratory results from different sample types
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Sampling date Serum potassium (mmol/L) Thrombocytes  (x109/L) Hydroxycarbamide treatment
24.7.2017. 4.7 245 No
25.7.2017. 4.6 321 No
26.7.2017. 4.5 404 No
27.7.2017. 4.9 479 No
28.7.2017. 5.8 294 No
29.7.2017. 6.2 509 No
30.7.2017. 4.9 549 No
1.8.2017. 6.3 1305 Yes
2.8.2017. 6.4 1392 Yes
3.8.2017. 5.2 831 Yes
9.8.2017. 4.0 450 Yes
Table 2. Serum potassium concentration and platelet count after surgery
um heparin and lowest in whole blood. All results 
are included in Table 1.
A correlation between serum potassium concen-
tration and platelet count was found. The Spear-
man rank correlation coefficient of 11 consecutive 
paired values after surgery was 0.64 (P < 0.05). 
Data are presented in Table 2.
What happened?
This report demonstrated a case of pseudohyper-
kalemia due to a combination of thrombocytosis 
and leukocytosis in a patient with essential throm-
bocythemia. The concentration of potassium was 
much higher in serum than in plasma and whole 
blood. Centrifuged plasma showed higher potas-
sium concentration than whole blood. It may be 
assumed with high probability that centrifugation 
can also lead to cell destruction and a consequent 
increase in plasma potassium.
Discussion
The novelty of this case report consists in finding 
lower concentration of potassium in whole blood 
than in lithium heparin plasma after centrifuga-
tion. It may be explained by the fact that centrifu-
gation can cause breakdown of some cells, which 
in turn results in increased plasma potassium con-
centration.
Laboratory scientists generally have three options 
when dealing with elevated potassium. The first 
option is to review the serum indices, haemolysis 
specifically. In this case the haemolysis was not 
present. The second option is to look for patho-
physiological reasons and the third option is to 
consider pseudo reasons. The final decision on 
what potassium result is reported may require a 
consultation with clinical staff along with an inter-
pretative comment to aid clinical staff.
Pre-analytical phase is a continuous challenge for 
laboratory professionals. Haemolysis is the most 
frequent pre-analytical issue (9).
Potassium is also released from thrombocytes dur-
ing blood clotting. It explains higher potassium 
concentration in serum than in plasma even in 
healthy subjects. This difference is higher than 0.4 
mmol/L in patients with thrombocytosis (6). This is 
consistent with our results. If the whole blood 
sample is used, the proposed cut-off to avoid inap-
propriate treatment is 1 mmol/L (7). Leukocytosis 
is one of the causes of pseudohyperkalemia (10). 
Leukocytosis probably contributed to pseudohy-
perkalemia also in our patient.
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Hyperkalemia is a common complication in trans-
fusion of stored blood in critically ill patients (11). 
Haemolysis-caused pseudohyperkalemia in whole 
blood samples can also be measured by acid base 
analysers (12).
Our department has an internal policy document 
named “Reporting laboratory test results”. It speci-
fies two checks of laboratory test results. An inter-
pretative comment is advised for the second 
check, if suitable. In the case of hyperkalemia, the 
comment should primarily include evaluation of 
renal function tests and blood count (number of 
leukocytes and thrombocytes) (13,14). That is why 
it is practical to add the interpretative comment in 
special situations. Such a comment explains the 
situation and recommends further diagnostic al-
gorithm.
The major limitation of this work is that only a sin-
gle patient was included.
What YOU should / can do in your 
laboratory to prevent such errors.
•	 Thrombocytosis and extreme leukocytosis lead 
to pseudohyperkalemia in serum.
•	 Measurement of potassium in plasma confirms 
this condition.
•	 Reporting test results extended with an inter-
pretative comment including a recommenda-
tion of further diagnostic algorithm is helpful 
and has an important educational role.
•	 Centrifugation may contribute to pseudohy-
perkalemia in some cases.
•	 It is helpful to measure potassium in whole 
blood sample in evaluation of pseudohyper-
kalemia.
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